首页> 外文期刊>Advances in Animal and Veterinary Sciences >Evaluation of Anticancer, Analgesic and Anti-Inflammatory Activities of the Ethanolic Extract of Lepidium draba Linn. Leaves
【24h】

Evaluation of Anticancer, Analgesic and Anti-Inflammatory Activities of the Ethanolic Extract of Lepidium draba Linn. Leaves

机译:抗甲苯甲肾上腺素乙醇提取物的抗癌,镇痛和抗炎活性评价。树叶

获取原文
           

摘要

For the past decades, Lepidium Draba L. was used as one of the traditional medicine against various ailments in Iraq. But the scientific basis for such uses remains largely random. Therefore, the present study applied leaf extract of L. draba to evaluate scientifically its anticancer, analgesic and anti-inflammatory activities. The in vitro anticancer procedures were performed against human cancer cell lines (HeLa) by using different concentrations of L. draba extract that were 31.25, 62.5, 125, 250, 500 and 1000 μg/ml with an incubation period of 24, 48 and 72 hours for each. The analgesic activity was evaluated by both hot plate test and formalin test in Swiss Albino mice at the doses 100, 200, 300, 400 and 500 mg /kg body weight and compared with Aspirin (100 mg/kg body weight) as standard drug. The extract was also investigated for its anti-inflammatory activity at the same above mentioned doses using carrageenan induced mice paw edema method. The results revealed the clear cytotoxic activity of L. draba extract on the growth of HeLa cancer cell line and the effect was concentration-dependent. The treatment with 1000 μg/ml after 72 hrs caused highest inhibition in the viability of HeLa cells (57.65%). The extract showed significant (P<0.05) increase in hot plate reaction time and suppressed the licking activity of both phases. In the formalin test also it caused significant decrease (P<0.05) in paw oedema compared to Aspirin. It can be concluded that L. draba extract has a significant anticancer, analgesic, anti-inflammatory activities
机译:在过去的几十年中,Lepidium Draba L.被用作伊拉克各种疾病的传统医学之一。但这种用途的科学基础仍然很大程度上是随机的。因此,本研究应用L. Draba的叶子提取物,科学地评估其抗癌,镇痛和抗炎活动。通过使用31.25,62.5,125,250,500和1000μg/ ml的不同浓度的L. DRABA提取物对人癌细胞系(HELA)进行体外抗癌程序。培养期24,48和72每个小时。通过在剂量100,200,300,400和500mg / kg体重的瑞士白化小鼠中通过热板试验和福尔马林试验评价镇痛活性,并与阿司匹林(100mg / kg体重)作为标准药物。还研究了采用角叉菜胶诱导的小鼠PAW水肿方法的上述剂量的抗炎活性的抗炎症活性。结果表明,L. Draba提取物对HeLa癌细胞系生长的透明细胞毒性活性,效果依赖性。 72小时后用1000μg/ mL的处理引起了HeLa细胞的活力(57.65%)的最高抑制。提取物显示出显着的(P <0.05)热板反应时间增加,并抑制了两相的舔活性。在福尔马林测试中,与阿司匹林相比,它在PAW水肿中引起了显着的降低(P <0.05)。可以得出结论,L. Draba提取物具有显着的抗癌,镇痛,抗炎活动

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号